Glaxosmithkline Share News (GSK)

GSK refuses to be bounced into early consumer unit spin-off

By Ben Hirschler LONDON, Feb 3 (Reuters) - GlaxoSmithKline said on Wednesday it would not be pushed into an early spin-off or sale of its consumer health business, despite speculation the unit could be a target for the likes of Reckitt Benckiser or Procter & Gamble. Britain's biggest

UPDATE: Glaxo To Meet Revenue Target Early As It Reports In-Line 2015

BUZZ-GSK: Reverses course after Q4 results beat

** GlaxoSmithKline's shares up 2 pct, 3rd-largest FTSE 100 gainer, having earlier been down as much as 1.5 pct, after posting Q4 revenue and core EPS ahead of analyst consensus ** Q4 core EPS of 18.1p vs Reuters consensus 17.9p, revenue of 6.286 bln stg vs Reuters consensus of 6.256 bln stg

Glaxo To Meet Revenue Target Early As It Reports In-Line 2015 Results

RPT-New drugs help GSK offset drag of flagging Advair sales

(Repeats with no change in text) LONDON, Feb 3 (Reuters) - Growing demand for new drugs helped GlaxoSmithKline beat forecasts for fourth-quarter earnings by a small margin on Wednesday, offsetting a continued slide in sales of its older Advair respiratory medicine. Sales, in sterling

New drugs help GSK offset drag of flagging Advair sales

LONDON, Feb 3 (Reuters) - Growing demand for new drugs helped GlaxoSmithKline beat forecasts for fourth-quarter earnings by a small margin on Wednesday, offsetting a continued slide in sales of its older Advair respiratory medicine. Sales, in sterling terms, rose 2 percent to 6.29 billion p

LONDON MARKET MIDDAY: Pound Rises After Upbeat UK Service Sector Data

GlaxoSmithKline provides shot in the arm with final results

(ShareCast News) - GlaxoSmithKline posted full year results showing revenues increasing 6% and core earnings per share down 15%, slightly ahead of guidance, and reiterated its confidence that earnings growth would return in 2016 at double-digit levels. The pension fund favourite said it will pay an

WRAPUP 1-Quest for Zika vaccine widens; Africa, Asia deemed vulnerable

* U.N. agency launches Zika global response unit * Sanofi cites Zika's rapid spread in vaccine effort * Zika linked to severe birth defect microcephaly By Stephanie Nebehay and Dominique Vidalon GENEVA/PARIS, Feb 2 (Reuters) - The Zika virus could spread to Africa, Asia an

UPDATE: Glaxo Expands Immunotherapy Collaboration With Adaptimmune

GlaxoSmithKline Expands Immunotherapy Collaboration With Adaptimmune

Wednesday preview: GSK reports fourth quarter earnings

(ShareCast News) - GlaxoSmithKline on Wednesday reports its fourth quarter earnings and a trading update on its 2015 full year results. UBS expects the pharmaceutical giant to report fourth quarter sales of £6.2m and core operating profit of £1.6bn. Core earnings per share (EPS) is forecast to co

UPDATE 1-Sanofi launches hunt for Zika vaccine as disease fears grow

(Adds context, other companies in Zika vaccine race) By Dominique Vidalon and Ben Hirschler PARIS/LONDON, Feb 2 (Reuters) - Sanofi has launched a project to develop a vaccine against the Zika virus in the most decisive commitment yet by a major vaccine producer to fight the disease li

Earnings, Trading Statements Calendar - Week Ahead

UPDATE 3-Novartis hires Hospira's $90 mln man to save Alcon

* Sales and profits likely to stagnate this year * Head of Alcon eye division replaced with Canadian-born Ball * Novartis faces $1.4 bln restructuring charge, to save $1 bln annually by 2020 (Recasts) By John Miller ZURICH, Jan 27 (Reuters) - Fresh from engineering Hospi